InMode Ltd (INMD)

Currency in USD
13.92
+0.33(+2.43%)
Closed·
14.11+0.19(+1.36%)
·
INMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.5014.23
52 wk Range
12.7216.74
Key Statistics
Prev. Close
13.92
Open
13.59
Day's Range
13.5-14.23
52 wk Range
12.72-16.74
Volume
1.56M
Average Volume (3m)
916.27K
1-Year Change
-2.1785%
Book Value / Share
10.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
INMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.75
Upside
+20.33%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

InMode Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Analyst Ratings

1 Buy
5 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 16.75
(+20.33% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Baird
Hold14.00+0.57%17.00MaintainMay 07, 2026
Barclays
Buy19.00+36.49%21.00MaintainMay 07, 2026
BTIG
Hold---MaintainJan 26, 2026
Canaccord Genuity
Hold15.00+7.76%16.00MaintainDec 17, 2025
UBS
Hold16.00+14.94%16.25MaintainNov 06, 2025

InMode Ltd SWOT Analysis


Market Headwinds
InMode faces challenges in the aesthetic procedures market, impacting system sales and revenue growth despite its strong position in medical devices
Financial Outlook
Analysts project EPS of 1.88 for FY2024 and 2.27 for FY2025, with price targets ranging from $29 to $33, reflecting cautious optimism amid market uncertainties
Competitive Edge
Explore InMode's innovative product portfolio and market positioning, which analysts believe could drive long-term growth despite current industry slowdown
Strategic Potential
Delve into InMode's opportunities for market expansion, product innovation, and diversification, balancing against regulatory risks and economic factors
Read full SWOT analysis

InMode Ltd Earnings Call Summary for Q1/2026

  • Q1 2026 revenue hit $82.02M (up 5% YoY), beating estimates by 3.27%, but EPS of $0.25 missed forecast of $0.30 by 16.67%
  • Stock fell 7.99% in premarket to $13.25 as gross margin compressed to 75% from 78% YoY amid rising operating expenses
  • International sales accounted for 48% of revenue; U.S. market drove growth despite profitability pressures from new product launches
  • Company expects Erbium laser FDA clearance by end of Q2 2026; investing in new laser platforms despite current margin headwinds
  • Operating cash flow reached $15.4M; management cited competitive pressures from injectables/GLP-1 treatments and macro challenges
Last Updated: 2026-05-06, 09:32 a/m
Read Full Transcript

Earnings

Latest Release
May 06, 2026
EPS / Forecast
0.25 / 0.30
Revenue / Forecast
82.02M / 79.42M
EPS Revisions
Last 90 days

INMD Income Statement

Compare INMD to Peers and Sector

Metrics to compare
INMD
Peers
Sector
Relationship
P/E Ratio
10.1x−1.5x−0.6x
PEG Ratio
−0.24−0.160.00
Price/Book
1.3x2.7x2.6x
Price / LTM Sales
2.4x3.4x3.2x
Upside (Analyst Target)
17.7%104.7%48.1%
Fair Value Upside
Unlock1.2%5.8%Unlock

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
6.90M10.88%95.98M
Other Institutional Investors
27.71M43.74%385.73M
Public Companies & Retail Investors
28.75M45.38%400.24M
Total
63.36M100.00%881.95M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
DOMA Perpetual Capital Management, LLC4.48%2,838,43139,511
Acadian Asset Management LLC4.10%2,596,48936,143

People Also Watch

19.16
PGNY
+2.46%
68.17
PRLB
-1.05%
39.91
KMX
+1.22%
21.770
REP
-0.18%

FAQ

What Is the InMode (INMD) Stock Price Today?

The InMode stock price today is 13.92 USD.

What Stock Exchange Does InMode Trade On?

InMode is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for InMode?

The stock symbol for InMode is "INMD."

What Is the InMode Market Cap?

As of today, InMode market cap is 881.95M USD.

What Is InMode's Earnings Per Share (TTM)?

The InMode EPS (TTM) is 1.36.

When Is the Next InMode Earnings Date?

InMode will release its next earnings report on Jul 23, 2026.

From a Technical Analysis Perspective, Is INMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has InMode Stock Split?

InMode has split 1 times.

How Many Employees Does InMode Have?

InMode has 660 employees.

What is the current trading status of InMode (INMD)?

As of May 08, 2026, InMode (INMD) is trading at a price of 13.92 USD, with a previous close of 13.92 USD. The stock has fluctuated within a day range of 13.50 USD to 14.23 USD, while its 52-week range spans from 12.72 USD to 16.74 USD.

What Is InMode (INMD) Price Target According to Analysts?

The average 12-month price target for InMode is 16.75 USD, with a high estimate of 21 USD and a low estimate of 14 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +20.33% Upside potential.

What Is the INMD After Hours Price?

INMD's last after hours stock price is 14.11 USD, the stock has decreased by 0.19, or 1.36%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.